Glaucoma damage reduced by rheumatoid arthritis drugs

TNF-alpha blockers could be a novel way of reducing ocular pressure in glaucoma, US researchers have found.

The drugs, commonly used to treat rheumatoid arthritis, could be an alternative to surgery or beta-blocker eye drops currently used to reduce ocular pressure.  

For the study, mice underwent laser irradiation in one eye. The irradiation induced intraocular hypertension, a risk factor for glaucoma and resultant damage to oligodendrocytes and retinal ganglion cells.  

Levels of TNF-alpha were almost five times higher in the retinal tissue of eyes with ocular hypertension than control eyes. Ocular hypertension was also associated with elevated levels of microgilia cells, which are part of the immune defence of the eye.  

Examination of the retina showed that in eyes with induced ocular pressure, oligodendrocytes were being destroyed resulting in a progressive loss of retinal ganglion cells.  

In mice lacking genes that encode TNF-alpha or its receptor TNFR2, this process did not happen.  

Similarly, loss of oligodendrocytes and retinal ganglion cells was prevented if mice were given TNF-alpha blockers.  

The researchers concluded that TNF-alpha provides an essential link between ocular hypertension and retinal ganglion cell loss in vivo.  

Co-author of the study, Dr Joan Miller, chief of ophthalmology at the Massachusetts Eye and Ear Infirmary, said: ‘It might be possible to put slow-release TNF-alpha inhibitors just outside the eye.’  

Concerns over the long-term effects of TNF-alpha blockers mean an alternative treatment needs to be developed.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs demand 'triple lock' on ARRS budgets as unfunded pay rise threatens recruitment

GPs demand 'triple lock' on ARRS budgets as unfunded pay rise threatens recruitment

PCNs will be unable to hire the staff they need to support general practice because...

Medeconomics becomes GP Business

Medeconomics becomes GP Business

Our relaunched site, GP Business, supports best practice in finance, management and...

GP to complete COVID-19 boosters in care homes by 1 November

GP to complete COVID-19 boosters in care homes by 1 November

GP-led COVID-19 vaccination sites have been told to prioritise booster jabs for patients...

NHS aims to vaccinate most 12- to 15-year-olds against COVID-19 by October half term

NHS aims to vaccinate most 12- to 15-year-olds against COVID-19 by October half term

NHS England is aiming to administer COVID-19 vaccines to most 12- to 15-year-olds...

BMA demands ‘immediate QOF suspension’ as GPs prepare for booster campaign

BMA demands ‘immediate QOF suspension’ as GPs prepare for booster campaign

The BMA has called for an 'immediate suspension' of QOF with income protection to...

'Out of touch' Javid deepens rift with GPs over face-to-face appointments

'Out of touch' Javid deepens rift with GPs over face-to-face appointments

GP leaders have accused Sajid Javid of being out of touch with reality after he told...